Tenpoint Therapeutics
ScaleupBiotech & Life Sciences
Tenpoint Therapeutics is a UK-based biopharmaceutical company focused on ophthalmology, best known for YUVEZZI, the first FDA-approved dual-agent combination eye drop for presbyopia, which received US regulatory approval in January 2026. The company raised $235 million in debt and equity to support commercialisation and has a growing pipeline in vision correction.
Locations
London, United Kingdom
London Innovation Centre, 20 Water Street, 4th Floor, Office 3, Wood Wharf, London, Greater London, E14 9GG, United Kingdom
View on mapWarren, United States (Headquarters)
25 Independence Blvd, Suite 100, Warren, New Jersey, 07059, United States
View on map